Advertisement

Ads Placeholder
US Stocks

HTSUF Hisamitsu Pharmaceutical (PNK) $29.00 16 Feb 2026: Oversold bounce setup

February 16, 2026
5 min read
Share with:

On market hours 16 Feb 2026 HTSUF stock trades at $29.00, presenting a classic oversold bounce setup for short-term traders. Volume is light at 100.00 shares versus an average of 90.00, keeping price moves contained. The snapshot shows a one-year range of $24.56–$32.30, P/E 16.76, and EPS 1.73, all relevant to a bounce-from-support approach. We outline technical triggers, valuation checks, and a targeted price path for traders considering a measured entry.

HTSUF stock: Market snapshot and immediate technical trigger

Hisamitsu Pharmaceutical Co., Inc. (HTSUF) is quoted on the PNK exchange in the United States at $29.00 (USD). The stock opened at $29.00 and remains flat on light volume 100.00. Day range is tight at $29.00–$29.00, indicating reduced intraday volatility and a possible short-term consolidation before a bounce. Traders should watch a decisive move above the 50-day average at $29.00 for confirmation of a rebound.

Advertisement

Valuation and fundamentals: HTSUF stock metrics to watch

Fundamentals support a conservative bounce trade. HTSUF shows EPS 1.73, P/E 16.76, price-to-book 1.17, and dividend yield 2.44%. Market cap is $2,032,119,175.00 with 70,073,075 shares outstanding. The company reports strong cash per share (1,562.03) and a current ratio of 3.77, which reduces financial stress risk during short-term drawdowns.

Technical analysis and Meyka stock grade for HTSUF stock

Price action fits an oversold bounce strategy: the stock is near recent support around $29.00 and the 200-day average sits at $29.41, creating a tight risk band. Meyka AI rates HTSUF with a score out of 100: 71.74 | Grade: B+ | Suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These ratings inform a measured long bias, not a guarantee of outcome.

Growth drivers, catalysts and risks for HTSUF stock

Hisamitsu’s product mix — SALONPAS and transdermal patches — supports steady revenue growth. FY 2025 shows revenue growth 10.09% and EPS growth 62.75%, which underpin the bounce thesis. Key risks include slower international rollouts and currency exposure given headquarters in Japan. Watch upcoming earnings on 2026-04-08 and any product trial updates that could swing sentiment.

Trading plan: oversold bounce strategy for HTSUF stock

Entry: consider partial buys near $29.00 with a stop-loss below $28.00 to limit downside. Target zones: $34.50 (near quarterly forecast) and $32.30 (year high) for staged profit-taking. Position sizing should respect low liquidity (avg vol 90.00) and use limit orders. A confirmed reversal above $29.41 (200-day average) improves risk/reward for swing traders.

Outlook and price targets: model-based view for HTSUF stock

Meyka AI’s forecast model projects short-to-medium targets that fit an oversold bounce theme. Monthly target is $29.36, quarterly target $34.61, and 12-month projection $26.14, reflecting both upside on a near-term recovery and potential medium-term mean reversion. Use the quarterly target $34.61 as an optimistic bounce objective and the yearly $26.14 as a cautionary marker for reconfirmation of trend.

Final Thoughts

Key takeaways for HTSUF stock during market hours on 16 Feb 2026: the stock trades at $29.00 on the PNK exchange with light volume 100.00, tight technicals, and a supportive fundamental profile (P/E 16.76, EPS 1.73, dividend yield 2.44%). The oversold bounce setup favors short-term long positions while protecting downside with a stop below $28.00. Meyka AI’s forecast model projects a quarterly target of $34.61 and a 12-month level of $26.14, giving a clear trade plan: staged buying into $29.00 support, confirm above $29.41, then scale toward $34.61. Forecasts are model-based projections and not guarantees. For the latest filings and company updates see the official Hisamitsu website and our HTSUF coverage on the Meyka platform at Meyka HTSUF page. Meyka AI provides this analysis as an AI-powered market analysis platform and not personalized investment advice.

Advertisement

FAQs

Is HTSUF stock a buy right now?

Meyka AI grades HTSUF B+ with a BUY suggestion. For an oversold bounce, consider partial buying near $29.00 with stops under $28.00. This is not personalized advice; run your own checks.

What is the short-term price target for HTSUF stock?

Short-term model and technicals point to a quarterly target around $34.61. Use staged exits and confirm momentum above the 200-day at $29.41 before adding size.

What risks should traders watch for HTSUF stock?

Primary risks include low liquidity (avg vol 90.00), FX exposure from Japan operations, and misses at the earnings date 2026-04-08. Tight stops and position sizing are essential.

How does valuation look for HTSUF stock?

Valuation is moderate: P/E 16.76, P/B 1.17, dividend yield 2.44%, and strong cash per share 1,562.03. These metrics support a cautious bounce trade with defined risk controls.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

Advertisement

Ads Placeholder
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
~15% average open rate and growing
Trusted by 10,000+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)